-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Fulvestrant is a synthetic steroidal molecule that is used in the treatment of breast cancer.
It is a selective estrogen receptor modulator (SERM) that operates by blocking the effects of estrogen on breast tissue, thereby preventing the growth and proliferation of cancer cells that are estrogen-receptor positive.
Fulvestrant was first synthesized in the 1970s, and since then, it has become an important drug in the treatment of breast cancer.
There are several synthetic routes that have been developed for the production of fulvestrant.
One of the most common methods involves the synthesis of the natural steroid precursor, androst-4-ene-3,17-dion, which is then converted to fulvestrant through a series of chemical reactions.
This route involves several steps, including the reduction of the keto-form of androst-4-ene-3,17-dion to the hydroxy-form, followed by a series of hydrogenation and reduction steps to obtain the final product.
Another synthetic route involves the synthesis of fulvestrant from the natural steroid precursor, dehydroepiandrosterone (DHEA), which is converted to androst-4-ene-3,17-dione through a series of chemical reactions.
This route involves several steps, including the reduction of DHEA to DHEA-3-one, followed by a series of chemical transformations to obtain the final product.
In recent years, several alternative synthetic routes for fulvestrant have been developed, including those that utilize enzymatic methods and microwave-assisted synthesis.
Enzymatic methods involve the use of enzymes to catalyze the formation of fulvestrant, while microwave-assisted synthesis involves the use of microwave radiation to accelerate the reaction rates and reduce the reaction times.
One of the advantages of synthetic routes for fulvestrant is that they allow for the production of large quantities of the drug at a relatively low cost.
In addition, they provide a level of control over the production process that is not possible with natural sources of the drug.
This allows for the production of a consistent and pure product, which is essential for the effective treatment of cancer.
